Fever in Patients With Cancer
- PMID: 28441374
- DOI: 10.1177/107327481702400212
Fever in Patients With Cancer
Abstract
Background: The definition of fever is flexible and depends on the clinical context. Fever is frequently observed in patients with cancer.
Methods: Infectious and noninfectious causes of fever in patients with various oncological and hematological malignancies and the usefulness of biomarkers are discussed.
Results: To treat patients in a timely manner and to minimize morbidity and mortality, it is paramount that health care professionals determine the cause of fever. The usefulness of biomarkers in febrile patients with cancer continues to be controversial.
Conclusions: Fever is frequently seen in patients with cancer and can be associated with a variety of infectious and noninfectious causes. The utility of acute-phase reactants, such as erythrocyte sedimentation rate, C-reactive protein, and procalcitonin, along with a nonsteroidal anti-inflammatory drug challenge should be further evaluated as adjunct tools for the workup of fever in patients with cancer.
Similar articles
-
[Old and new inflammatory biomarkers: what utility for general internist?].Rev Med Suisse. 2013 Oct 30;9(404):2008-10, 2012. Rev Med Suisse. 2013. PMID: 24313053 French.
-
Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.Eur J Clin Microbiol Infect Dis. 2004 Jul;23(7):539-44. doi: 10.1007/s10096-004-1156-y. Epub 2004 Jun 22. Eur J Clin Microbiol Infect Dis. 2004. PMID: 15221617
-
Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever.Support Care Cancer. 2004 Aug;12(8):593-8. doi: 10.1007/s00520-004-0602-9. Epub 2004 Feb 10. Support Care Cancer. 2004. PMID: 14770304
-
Evaluation of fever in the emergency department.Am J Emerg Med. 2017 Nov;35(11):1755-1758. doi: 10.1016/j.ajem.2017.08.030. Epub 2017 Aug 14. Am J Emerg Med. 2017. PMID: 28822610 Review.
-
Selected inflammatory markers in the diagnosis and monitoring of infections in children treated for hematological malignancies.Biomark Med. 2015;9(5):461-71. doi: 10.2217/bmm.14.101. Biomark Med. 2015. PMID: 25985175 Review.
Cited by
-
Development of a Core Body Thermometer Applicable for High-Temperature Environment Based on the Zero-Heat-Flux Method.Sensors (Basel). 2023 Feb 9;23(4):1970. doi: 10.3390/s23041970. Sensors (Basel). 2023. PMID: 36850568 Free PMC article.
-
Efficacy and safety of early antibiotic de-escalation in febrile neutropenia for patients with hematologic malignancy: a systematic review and meta-analysis.Antimicrob Agents Chemother. 2025 Apr 2;69(4):e0159724. doi: 10.1128/aac.01597-24. Epub 2025 Mar 13. Antimicrob Agents Chemother. 2025. PMID: 40079575 Free PMC article.
-
Kinetics of cell-free DNA in response to exogenous and exertional heating in healthy young men.Eur J Appl Physiol. 2025 Jul 3. doi: 10.1007/s00421-025-05861-8. Online ahead of print. Eur J Appl Physiol. 2025. PMID: 40608069
-
Neoplastic Fever: A Rare Differential of Intractable Fever.J Obstet Gynaecol India. 2023 Dec;73(6):538-540. doi: 10.1007/s13224-023-01744-0. Epub 2023 Mar 17. J Obstet Gynaecol India. 2023. PMID: 38205106 Free PMC article. No abstract available.
-
Treatment decision for cancer patients with fever during the coronavirus disease 2019 (COVID-19) pandemic.Yeungnam Univ J Med. 2021 Oct;38(4):344-349. doi: 10.12701/yujm.2021.01144. Epub 2021 Aug 23. Yeungnam Univ J Med. 2021. PMID: 34420277 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials